跳至主要内容
临床试验/ISRCTN07263575
ISRCTN07263575已完成不适用

Efficacy of inhaled recombinant human deoxyribonuclease in mechanically ventilated pediatric patients with an atelectasis

Erasmus Medical Center, Sophia Children's Hospital (Netherlands)0 个研究点目标入组 80 人开始时间: 2006年9月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged zero to 18 years
  • 2. Mechanical ventilation
  • 3. Presence of an atelectasis on a chest radiograph
  • 4. First dose of study medication can be administered preferably within six hours (maximum 12 hours) after an atelectasis has been diagnosed

排除标准

  • 1. Children with neuromuscular disorders and impaired ability to cough, cardiomyopathy, or cystic fibrosis
  • 2. Post-gestational age less than 32 weeks
  • 3. Mechanical ventilation during muscle paralysis
  • 4. Atelectasis due to a bronchoscopically diagnosed:
  • a. foreign body aspiration
  • b. tracheal or bronchial compression by lymph nodes or vessels
  • 5. Recurrent atelectasis due to an anatomical airway-abnormality
  • 6. RhDNase treatment in the previous 48 hours
  • 7. Clinical condition or ventilator settings that are not compatible with nebulising medication (according to the responsible physician)
  • 8. Presence of a pneumothorax
  • 9. Previous participation in the study

研究者

发起方
Erasmus Medical Center, Sophia Children's Hospital (Netherlands)

相似试验

Unknown
2 期
Time of Ventilation and Lung Function of Ventilated Patients Under Therapy With Dornase AlfaLong Term Ventilation
NCT00204685University Hospital Tuebingen540
已完成
不适用
Efficacy of peripherally targeted inhaled rhDNase for persistent obstructive asthma in childhood.asthma with persistent obstructive pulmonary function.
NL-OMON21320ErasmusMC Rotterdam60
进行中(未招募)
不适用
Efficacy of peripherally targeted inhaled rhDNase for persistent obstructive asthma in childhoodAsthma is a chronic inflammatory disorder in which many cells play a role, in particular mast cells, eosinophils and T lymphocytes. In susceptible individuals this inflammation causes recurrent episodes of wheezing, breathlessness, chest tightness and cough. These symptoms are usually associated with widespread but variable airflow limitation that is at least partly reversible either spontaneously or with treatment.MedDRA version: 8.1Level: LLTClassification code 10003553Term: Asthma
EUCTR2006-002337-20-NLErasmus Medical Centre Rotterdam60
已完成
不适用
Efficacy of peripherally targeted inhaled rhDNase for persistent obstructive asthma in childhoodObstructive pulmonary function, asthmaRespiratoryObstructive pulmonary disease, asthma
ISRCTN71537084Erasmus Medical Center (The Netherlands)60
已完成
不适用
Peripheral targeting of inhaled recombinant human deoxyribonuclease in stable cystic fibrosis patientsNutritional, Metabolic, EndocrineMetabolic disordersCystic fibrosis
ISRCTN64225851Erasmus Medical Centre (The Netherlands)50